139356-38-0

Basic information

• Product Name: ((1R,3R)-5-(2-chloroethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane)
• Synonyms: ((1R,3R)-5-(2-chloroethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane)
• CAS NO: 139356-38-0
• Molecular Weight: 405.168
• Mol File: 139356-38-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: ((1R,3R)-5-(2-chloroethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane)(CAS DataBase Reference)
• NIST Chemistry Reference: ((1R,3R)-5-(2-chloroethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane)(139356-38-0)
• EPA Substance Registry System: ((1R,3R)-5-(2-chloroethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane)(139356-38-0)

Safety Data

• Hazardous Substances Data: 139356-38-0(Hazardous Substances Data)

Usage

Description

((1R,3R)-5-(2-chloroethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) is a complex organic compound characterized by a cyclohexane-1,3-diyl backbone with two (oxy) groups and two tert-butyldimethylsilane groups attached to the oxygen atoms. It also features a chloroethylidene group connected to one of the carbon atoms in the cyclohexane ring. This unique structure and the presence of various functional groups make it a promising candidate for a range of industrial and pharmaceutical applications.

Uses

Used in Pharmaceutical Industry:
((1R,3R)-5-(2-chloroethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) is used as a pharmaceutical intermediate for the synthesis of various drugs and active pharmaceutical ingredients. Its unique structure and functional groups enable it to serve as a key building block in the development of new medications.
Used in Chemical Synthesis:
In the field of chemical synthesis, ((1R,3R)-5-(2-chloroethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) is used as a versatile reagent and precursor in the preparation of a wide range of organic compounds. Its chloroethylidene and tert-butyldimethylsilane groups can be utilized in various chemical reactions, making it a valuable component in the synthesis of complex organic molecules.
Used in Material Science:
((1R,3R)-5-(2-chloroethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) is employed in material science as a component in the development of advanced materials with specific properties. Its unique structure and functional groups can contribute to the creation of materials with tailored characteristics, such as improved stability, reactivity, or selectivity, depending on the application.
Used in Research and Development:
In research and development, ((1R,3R)-5-(2-chloroethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) serves as a valuable compound for studying the properties and behavior of complex organic molecules. Its unique structure and functional groups make it an interesting subject for investigations into chemical reactions, mechanisms, and the development of new synthetic methods.

Upstream product

• 262594-22-9 methyl (3S,5R)-3,5-di[(tert-butyldimethylsilyl)oxy]-cyclohex-1-enecarboxylate 
• 101906-39-2 Methyl (3R,4R,5R)-3,5-Bis<(tert-butyl)dimethylsilyloxy>-4-hydroxycyclohex-1-ene-1-carboxylate 
• 40983-58-2 methyl shikimate 
• 138-59-0 shikimic acid 
• 139356-37-9 [(3R,5R)-3,5-bis-(tert-butyldimethylsilanyloxy)cyclohexylidene]-ethanol 
• 124-63-0 methanesulfonyl chloride 
• 191916-39-9 methyl (-)-quinate 
• 77-95-2 D-(-)-quinic acid 
• 139356-32-4 methyl (1s_n,3R,4s_n,5R)-3,5-di[(tert-butyldimethylsilyl)oxy]-1-hydroxy-4-[(imidazol-1-ylthiocarbonyl)oxy]-cyclohexanecarboxylate 
• 139356-36-8 [(3R,5R)-3,5-bis-(tert-butyldimethylsilyloxy)cyclohexylidene]acetic acid ethyl ester 
• 139356-33-5 (3S,5S)-3,5-bis[(tert-butyl)dimethylsilyloxy]-1-hydroxycyclohexane-1-carboxylic acid methyl ester 
• 139356-35-7 3,5-di-(tert-butyl-dimethylsilyloxy)-(3S,5S)-cyclohexan-1-one 
• 139356-34-6 (3S,5S)-3,5-bis[tert-butyl(dimethyl)silyloxy]-1-(hydroxylmethyl)cyclohexanol 
• 135711-62-5 methyl quinicate 

Downstream Products

• 130447-37-9 1α,25-dihydroxy-19-nor-vitamin D₃ 
• 139356-40-4 (1R,7aR)-4-[2-[(3R,5R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-cyclohexylidene]-eth-(E)-ylidene]-1-((R)-1,5-dimethyl-5-trimethylsilanyloxy-hexyl)-7a-methyl-octahydro-indene 
• 139356-39-1 (1R,3R)-1,3-bis((tert-butyldimethyl)silanyloxy)-5-[2-(diphenylphosphinoyl)-ethylidene]cyclohexane 
• 142777-78-4 (S)-2-((1R,3aS,7aR,E)-4-(2-((3R,5R)-3,5-bis(tertbutyldimethylsilyloxy)cyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)propanal 
• 957214-02-7 ((1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((S)-1,1-dimethoxypropan-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tertbutyldimethylsilane) 

Relevant articles and documents

Preparation method of paricalcitol intermediate

The invention discloses a preparation method of a paricalcitol intermediate, which includes the following steps: (1) shikimic acid is esterified; (2) hydroxyl groups at sites 3 and 5 are selectively protected; (3) hydroxyl group at site 4 is protected by

1-DEOXY ANALOGS OF VITAMIN D-RELATED COMPOUNDS

This present disclosure is directed to novel prodrugs of activated vitamin D3 compounds. The prodrugs can be designed to have one or more beneficial properties, such as selective inhibition of the enzyme CYP24, low calcemic activity, and anti-proliferativ

Novel synthesis of 19-nor-vitamin D compounds

1α,25-Dihydroxy-19-nor-vitamin D3 was prepared efficiently in a convergent synthesis starting with (-)-quinic acid and a ketone of the Windaus-Grundmann type.